Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 26912 | 242 | 28.4 | 49% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
| 392 | 3 | HEALTH LITERACY//HYPERTENSION//MEDICATION ADHERENCE | 30562 |
| 406 | 2 | HYPERTENSION//MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION | 16649 |
| 26912 | 1 | 24H ABP//ADVERSE EXPERIENCE REPORTING//ANTIHYPERTENSIVE DRUG USAGE | 242 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | 24H ABP | authKW | 126179 | 0% | 100% | 1 |
| 2 | ADVERSE EXPERIENCE REPORTING | authKW | 126179 | 0% | 100% | 1 |
| 3 | ANTIHYPERTENSIVE DRUG USAGE | authKW | 126179 | 0% | 100% | 1 |
| 4 | AUDIT PROTOCOL | authKW | 126179 | 0% | 100% | 1 |
| 5 | CATALONIA PROGRAMME | address | 126179 | 0% | 100% | 1 |
| 6 | CCORT | authKW | 126179 | 0% | 100% | 1 |
| 7 | CHOICE OF DRUG | authKW | 126179 | 0% | 100% | 1 |
| 8 | CITI2 | address | 126179 | 0% | 100% | 1 |
| 9 | CONTROL PROJECTS | authKW | 126179 | 0% | 100% | 1 |
| 10 | COST GOVERNMENT INTERVENTION | authKW | 126179 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Peripheral Vascular Diseases | 2185 | 28% | 0% | 68 |
| 2 | Health Policy & Services | 1074 | 11% | 0% | 27 |
| 3 | Health Care Sciences & Services | 769 | 12% | 0% | 30 |
| 4 | Medicine, General & Internal | 678 | 25% | 0% | 61 |
| 5 | Cardiac & Cardiovascular System | 403 | 17% | 0% | 41 |
| 6 | Pharmacology & Pharmacy | 206 | 19% | 0% | 46 |
| 7 | Public, Environmental & Occupational Health | 99 | 10% | 0% | 23 |
| 8 | Geriatrics & Gerontology | 27 | 2% | 0% | 5 |
| 9 | Medical Informatics | 19 | 1% | 0% | 3 |
| 10 | Social Sciences, Biomedical | 16 | 1% | 0% | 3 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CATALONIA PROGRAMME | 126179 | 0% | 100% | 1 |
| 2 | CITI2 | 126179 | 0% | 100% | 1 |
| 3 | FUSE UK TRANSLAT PUBL HLTH | 126179 | 0% | 100% | 1 |
| 4 | HADASSAH EIN KAREM | 126179 | 0% | 100% | 1 |
| 5 | NEW CIVIL HOSP GUADALAJARA | 126179 | 0% | 100% | 1 |
| 6 | ABORAT PREVENT TREATMENT CARDIOVASC DIS | 63089 | 0% | 50% | 1 |
| 7 | CLIN EPIDEMIOL HLTH CARE PROGRAM MED | 63089 | 0% | 50% | 1 |
| 8 | CINDI | 42058 | 0% | 33% | 1 |
| 9 | HASHARON MED | 42058 | 0% | 33% | 1 |
| 10 | MARY IMOGENE BASSETT HOSP | 42058 | 0% | 33% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF HUMAN HYPERTENSION | 19859 | 10% | 1% | 24 |
| 2 | NEW ZEALAND MEDICAL JOURNAL | 17529 | 9% | 1% | 21 |
| 3 | HOSPITALS | 7167 | 3% | 1% | 7 |
| 4 | PHARMACOECONOMICS | 3661 | 3% | 0% | 8 |
| 5 | CLINICAL AND EXPERIMENTAL HYPERTENSION | 3099 | 3% | 0% | 7 |
| 6 | AMERICAN JOURNAL OF HYPERTENSION | 3069 | 5% | 0% | 12 |
| 7 | BLOOD PRESSURE | 2075 | 2% | 0% | 4 |
| 8 | JOURNAL OF HYPERTENSION | 1869 | 5% | 0% | 12 |
| 9 | DRUG INFORMATION JOURNAL | 1832 | 2% | 0% | 4 |
| 10 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1135 | 4% | 0% | 10 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | 24H ABP | 126179 | 0% | 100% | 1 | Search 24H+ABP | Search 24H+ABP |
| 2 | ADVERSE EXPERIENCE REPORTING | 126179 | 0% | 100% | 1 | Search ADVERSE+EXPERIENCE+REPORTING | Search ADVERSE+EXPERIENCE+REPORTING |
| 3 | ANTIHYPERTENSIVE DRUG USAGE | 126179 | 0% | 100% | 1 | Search ANTIHYPERTENSIVE+DRUG+USAGE | Search ANTIHYPERTENSIVE+DRUG+USAGE |
| 4 | AUDIT PROTOCOL | 126179 | 0% | 100% | 1 | Search AUDIT+PROTOCOL | Search AUDIT+PROTOCOL |
| 5 | CCORT | 126179 | 0% | 100% | 1 | Search CCORT | Search CCORT |
| 6 | CHOICE OF DRUG | 126179 | 0% | 100% | 1 | Search CHOICE+OF+DRUG | Search CHOICE+OF+DRUG |
| 7 | CONTROL PROJECTS | 126179 | 0% | 100% | 1 | Search CONTROL+PROJECTS | Search CONTROL+PROJECTS |
| 8 | COST GOVERNMENT INTERVENTION | 126179 | 0% | 100% | 1 | Search COST+GOVERNMENT+INTERVENTION | Search COST+GOVERNMENT+INTERVENTION |
| 9 | COST OF ANTIHYPERTENSIVE MEDICATIONS | 126179 | 0% | 100% | 1 | Search COST+OF+ANTIHYPERTENSIVE+MEDICATIONS | Search COST+OF+ANTIHYPERTENSIVE+MEDICATIONS |
| 10 | HEALTH AND DISEASE MANAGEMENT HYPERTENSION | 126179 | 0% | 100% | 1 | Search HEALTH+AND+DISEASE+MANAGEMENT+HYPERTENSION | Search HEALTH+AND+DISEASE+MANAGEMENT+HYPERTENSION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | AMBROSIONI, E , (2001) PHARMACOECONOMICS OF HYPERTENSION MANAGEMENT - THE PLACE OF COMBINATION THERAPY.PHARMACOECONOMICS. VOL. 19. ISSUE 4. P. 337 -347 | 25 | 39% | 18 |
| 2 | AMBROSIONI, E , (2001) HEALTHCARE BENEFITS OF VERY-LOW-DOSE COMBINATION TREATMENT USED IN THE MANAGEMENT OF HYPERTENSION.JOURNAL OF HYPERTENSION. VOL. 19. ISSUE . P. S29 -S36 | 25 | 38% | 4 |
| 3 | AMBROSIONI, E , (2001) PHARMACOECONOMIC CHALLENGES IN DISEASE MANAGEMENT OF HYPERTENSION.JOURNAL OF HYPERTENSION. VOL. 19. ISSUE . P. S33 -S40 | 22 | 42% | 13 |
| 4 | JONSSON, BG , (1994) COST-BENEFIT OF TREATING HYPERTENSION.JOURNAL OF HYPERTENSION. VOL. 12. ISSUE . P. S65-S70 | 13 | 68% | 25 |
| 5 | KIISKINEN, U , VARTIAINEN, E , PUSKA, P , AROMAA, A , (1998) LONG-TERM COST AND LIFE-EXPECTANCY CONSEQUENCES OF HYPERTENSION.JOURNAL OF HYPERTENSION. VOL. 16. ISSUE 8. P. 1103 -1112 | 10 | 67% | 36 |
| 6 | JOHANNESSON, M , (1994) THE IMPACT OF AGE ON THE COST-EFFECTIVENESS OF HYPERTENSION TREATMENT - AN ANALYSIS OF RANDOMIZED DRUG TRIALS.MEDICAL DECISION MAKING. VOL. 14. ISSUE 3. P. 236-244 | 13 | 59% | 28 |
| 7 | (1995) ECONOMICS OF HYPERTENSION CONTROL.BULLETIN OF THE WORLD HEALTH ORGANIZATION. VOL. 73. ISSUE 4. P. 417-424 | 12 | 60% | 0 |
| 8 | ATHANASAKIS, K , SOULIOTIS, K , TOUNTAS, Y , YFANTOPOULOS, J , KYRIOPOULOS, J , HATZAKIS, A , (2014) A SHORT-TERM COST-EFFECTIVENESS ANALYSIS OF HYPERTENSION TREATMENT IN GREECE.HELLENIC JOURNAL OF CARDIOLOGY. VOL. 55. ISSUE 3. P. 197 -203 | 11 | 37% | 0 |
| 9 | KRZYSZTOSZEK, J , KOLIGAT, D , RATAJCZAK, P , BRYL, W , CYMERYS, M , HOFFMANN, K , WIERZEJSKA, E , KLEKA, P , (2014) ECONOMIC ASPECTS OF HYPERTENSION TREATMENT IN POLAND.ARCHIVES OF MEDICAL SCIENCE. VOL. 10. ISSUE 3. P. 607 -617 | 9 | 41% | 2 |
| 10 | JOHANNESSON, M , (1994) THE COST-EFFECTIVENESS OF THE SWITCH TOWARDS MORE EXPENSIVE ANTIHYPERTENSIVE DRUGS.HEALTH POLICY. VOL. 28. ISSUE 1. P. 1-13 | 10 | 56% | 19 |
Classes with closest relation at Level 1 |